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Abstract
p38 mitogen-activated protein kinases (MAPKs) respond to a wide range of extracellular stimuli. While the inhibition of p38
signaling is implicated in the impaired capacity to repair ultraviolet (UV)-induced DNA damage—a primary risk factor for
human skin cancers—its mechanism of action in skin carcinogenesis remains unclear, as both anti-proliferative and survival
functions have been previously described. In this study, we utilized cultured keratinocytes, murine tumorigenesis models,
and human cutaneous squamous cell carcinoma (SCC) specimens to assess the effect of p38 in this regard. UV irradiation of
normal human keratinocytes increased the expression of all four p38 isoforms (a/b/c/d); whereas irradiation of p53-deficient
A431 keratinocytes derived from a human SCC selectively decreased p38a, without affecting other isoforms. p38a levels are
decreased in the majority of human cutaneous SCCs assessed by tissue microarray, suggesting a tumor-suppressive effect of
p38a in SCC pathogenesis. Genetic and pharmacological inhibition of p38a and in A431 cells increased cell proliferation,
which was in turn associated with increases in NAPDH oxidase (NOX2) activity as well as intracellular reactive oxygen species
(ROS). These changes led to enhanced invasiveness of A431 cells as assessed by the matrigel invasion assay. Chronic
treatment of p53-/-/SKH-1 mice with the p38 inhibitor SB203580 accelerated UV-induced SCC carcinogenesis and increased
the expression of NOX2. NOX2 knockdown suppressed the augmented growth of A431 xenografts treated with SB203580.
These findings indicate that in the absence of p53, p38a deficiency drives SCC growth and progression that is associated
with enhanced NOX2 expression and ROS formation.
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Introduction
Exposure to solar ultraviolet (UV) radiation is a primary risk
factor for human skin carcinogenesis. In addition to its ability to
induce mutagenic DNA damage, UV radiation induces extensive
cellular damage through a variety of mechanisms, including
augmented production of intracellular reactive oxygen species
(ROS) [1]. Augmented ROS and consumption of physiological
antioxidants drive signaling mechanisms involved in tumor
promotion and progression [1–3]. Intracellular ROS are primarily
generated through aerobic metabolism or through a specialized
group of enzymes, known as the NADPH oxidases, in which NOX
is the catalytic subunit [4,5]. NADPH oxidase activity is associated
with several characteristic features of cancer, including genomic
instability, cell proliferation, survival, invasion, and metastasis [6–
8]. Of the seven distinct NOX enzymes (NOX1–NOX5, Duox1,
and Duox2) that are known to exist in humans, NOX1-induced
ROS has been implicated in oncogenic signaling in Ras-
transformed NIH3T3 cells [9]. Moreover, increases in NADPH
oxidase activity and NOX1 levels are observed in human
cutaneous squamous cell carcinomas (SCCs) and keratinocytes of
individuals affected with xeroderma pigmentosum C (XPC), an
autosomal recessive disorder that is associated with compromised
nucleotide excision repair that leads to accelerated development of
multiple types of skin cancer [10,11]. Despite the evidence
supporting the role of oxidative stress in skin cancer, the molecular
pathways involved in skin carcinogenesis are not fully understood.
p38 mitogen-activated protein kinases (MAPKs) are activated in
response to a wide range of extracellular stimuli, including among
others osmotic and thermal stress, growth factors, inflammatory
cytokines, and UV radiation. p38 influences various cellular
processes, including proliferation, differentiation, apoptosis, and
inflammation [12]. Four p38 MAPK isoforms have been
identified, including a, b, c, and d. Among these four isoforms,
p38a and p38b have overlapping functions; meanwhile, p38c and
p38d are structurally similar to each other, but distantly related to
both p38a and p38b [13] [14]. Furthermore, p38a and p38d are
abundantly expressed in epidermis, whereas p38b or p38c are
virtually undetectable in normal epidermis [15,16]. p38a has also
been shown to be responsive to UV irradiation and plays an
important role in the regulation of cell-cycle arrest and apoptosis
[17]. The exact role of p38a in cancer, however, remains
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controversial. Both anti-proliferative and survival functions of
p38a have been described [18–21]. For example, p38a can
negatively regulate cell cycle progression at both the G1/S and
G2/M transitions, via downregulation of cyclins and upregulation
of cyclin-dependent kinase inhibitors [18,19]. In contrast, pro-
survival roles of p38 have also been observed during the G2 DNA
damage checkpoint response, through the upregulation of the Bcl2
family proteins [20], or via induction of a quiescent state known as
cancer dormancy, which may be an important mechanism for
acquisition of drug resistance by cancer cells [21]. These dualistic
effects of p38a also occur in skin carcinogenesis. Autophagy-
associated decreased p38 phosphorylation enhances cell survival
and UVB-induced SCC carcinogenesis in murine models [22]. In
contrast, chronic UV irradiation of p38a-dominant negative (p38a
DN) mice diminished the growth of skin tumors [23]. The cause of
these disparate effects are not clear but interplay with other
signaling pathways, as well as the nature of p38 MAPK substrates,
could account for them [24]. For example, p38 activates the p53
tumor suppressor, and the p53 pathway is known to synergize p38
MAPK signaling, suggesting cross-talk between these two path-
ways [25]. Nonetheless, UV-induced mutational inactivation of
p53 is a common finding in sun-exposed skin, and the majority of
human SCCs harbor p53 mutations. Using p53-deficient SCC
keratinocytes and p53-/-/SKH-1 mice, we assessed the role of
p38a to explore the connection between p38a and NOX-
mediated ROS generation. Our results indicate that chemical
inhibition of p38 activity enhances UV-induced SCC growth in
p53-/-/SKH-1 mice, which is accompanied by increased NOX2
expression and elevated intracellular ROS levels.
Materials and Methods
Cells and Reagents
A431 human epidermoid squamous cell carcinoma (SCC) cells
were obtained from the American Type Culture Collection
(ATCC, Manassas, VA) and maintained according to ATCC
guidelines. Primary human keratinocytes isolated from neonatal
foreskin were obtained from Columbia University Skin Disease
Research Center (SDRC) tissue culture core facility and cultured
in 154CF medium supplemented with human keratinocyte growth
supplement (Life Technologies, Grand Island, NY). SB203580, a
pyridinyl imidazole inhibitor widely used to inhibit the biological
function of p38a/b [26–28], and diphenyleneiodonium (DPI), an
inhibitor of NADPH oxidase-mediated ROS formation, were
purchased from Sigma-Aldrich (St. Louis, MO). siRNA targeting
p38a coding regions and scrambled siRNA controls (con) were
obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
SB203580 was dissolved in DMSO for cell culture or in 0.5%
methylcellulose (Sigma-Aldrich) for oral administration to mice.
DPI was dissolved in dimethyl sulfoxide (DMSO) and added to cell
cultures at a final concentration of 2.5 mM. SCC tissue micro-
arrays (TMAs) were obtained from Imgenex (San Diego, CA).
siRNA transfection
A431 cells were transfected with 40 nM of p38a MAPK siRNA
or scrambled siRNAs using Lipofectamine RNAiMax (Santa Cruz
Biotechnology, Santa Cruz, CA). The efficiency of p38a
downregulation was assessed by RT-PCR and Western blotting
24 h–48 h after transfection.
qRT-PCR and Western blotting
Total RNA was isolated from whole skin or cultured cells using
the RNeasy Kit (Qiagen, Gaithersburg, MD) and treated with
DNase I (Life Technologies, Grand Island, NY) according to the
manufacturers’ protocols. Total RNA (2 mg) was then reverse
transcribed by Superscript III using random hexamer primers
according to the manufacturer’s instructions. Primers for each
gene are listed in Table 1. For Western blotting, protein was
isolated from whole skin or cultured cells following established
procedures [29]. Proteins were resolved on 4–15% SDS-PAGE
gels and blotted according to standard procedures using the
following primary antibodies: p38a, p38b, p38c, p38d, p-p38 and
cyclin D1 (Cell Signaling Technology, Danvers, MA), Cdc25C,
and phospho-c-Jun (Santa Cruz Biotechnology, Dallas, TX),
NOX2 (Abcam, Cambridge, MA), tubulin and b-actin (Sigma-
Aldrich, St. Louis, MO).
BrdU incorporation assay
A431 cell growth and proliferation following p38a siRNA-
treatment or scramble siRNA control (scr)-treatment were
analyzed by BrdU incorporation, following the manufacturer’s
instructions (BD Biosciences, San Jose, CA). For labeling, 24 h
after transfection, BrdU was added directly to the cell culture to a
final concentration of 100 mM, and cultures were incubated for
another 24 h, at which point cells were harvested, fixed,
permeabilized, treated with DNase I, and stained with a FITC-
conjugated anti-BrdU antibody (BD Biosciences, San Jose, CA).
Fluorescence intensity was measured using a fluorescence plate
reader.
Cell invasion assay
The invasiveness of p38a-depleted and control SCC cells was
assessed using BD BioCoat Matrigel Invasion Chambers, following
the manufacturer’s instructions (BD Biosciences, San Jose, CA).
Briefly, 16105 cells/well were plated onto the six-well plate and
allowed to grow overnight at 37uC. Cells invading the matrigel
were stained and counted.
Measurement of intracellular ROS
Intracellular ROS was assessed using a cell-permeable fluoro-
genic probe, 29,79-dichlorofluorescein diacetate (CM-H2DCF-DA)
dye (Life Technologies), which detects hydrogen peroxide
production. Briefly, 48 h following transfection of the p38a
siRNA or scrambled siRNA into A431 cells, CM-H2DCF-DA
was added to the cells at a final concentration of 5 mM and
incubated for 15 min at 37uC in the dark. CM-H2DCF-DA is
oxidized by cytoplasmic ROS to a green fluorescent CM-DCF
compound. After 2 washes with PBS, cells were detached by
trypsin-EDTA and immediately analyzed by flow cytometry;
16104 cells were collected and analyzed for each sample.
Measurement of NADPH oxidase activity
NADPH oxidase activity was measured in plasma membranes
obtained from A431 cells or tumor tissues. Specimens were
incubated in hypotonic buffer supplemented with protease
inhibitor cocktails (Sigma-Aldrich, St. Louis, MO) for 30 min on
ice. Following sonication, the homogenate was centrifuged at
10006g for 15 min at 4uC. The supernatant was collected and
centrifuged at 12,0006g for 1 h at 4uC. The pellet consisting of
crude membranes was resuspended in 50 ml 16PBS supplement-
ed with 0.9 mM CaCl2 and 0.5 mM MgCl2. After adding 200 ml
of solution containing 0.8 mM glucose, 2 mM luminol and
500 U/ml horseradish peroxidase, the reaction mixture was
incubated for 1 min at 37uC. Following the addition of 10 ng/
ml of phorbol myristate acetate (PMA), the RLU of chemilumi-
nescence were recorded every 30 seconds for a total of 90 minutes
at 37uC using a luminometer.
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Table 1. Primer sequences for real-time PCR.
Forward (59-39) Reverse (59-39)
GAPDH (human) AATGAAGGGGTCATTGATGG AAGGTGAAGGTCGGAGTCAA
p38a (human) TCAGTCCATCATTCATGCGAAA AACGTCCAACAGACCAATCAC
p38b (human) AAGCACGAGAACGTCATCGG TCACCAAGTACACTTCGCTGA
p38c (human) CATGAGAAGCTAGGCGAGGAC CAGCGTGGATATACCTCAGCC
p38d (human) GCCGAGATGACTGGCTACG TGGTCCAGGTAATCTTTCCCC
Nox2-1st (mouse) ACCCTTTGGTACAGCCAGTG TTGCAATGGTCTTGAACTCG
Nox2-2nd (mouse) CCTTTGCCTCCATTCTCAAG GTGCACAGCAAAGTGATTGG
doi:10.1371/journal.pone.0097245.t001
Figure 1. p38a MAPK expression is diminished in UV-irradiated A431 SCC keratinocytes and human SCCs. UV decreases p38a
expression in A431 cells. The mRNA levels of p38a, b, c, and d were determined by real-time qRT-PCR in normal human keratinocytes (NHK) and
human A431 cells, 24 h after UV irradiation (30 mJ/cm2).; The data shown are from a representative experiment of three different sets of independent
experiments using keratinocytes derived from independent donors. *p,0.05. (B) The levels of p38 isoforms in A431 cells were assessed by Western
blotting, 24 h after UV irradiation at the indicated UV doses. b-actin was used as an internal loading control; 50 mg protein was loaded per lane. (C)
Immunohistochemical analyses of p38a in human cutaneous SCCs. p38a expression in cutaneous SCC tissue arrays containing 35 SCC sections and
nine normal skin sections was analyzed by immunohistochemical staining. The signal intensity and the extent of staining were quantified using the
pixel analysis function of Adobe Photoshop. Two SCC samples were excluded from the following statistical analysis, due to excessive infiltrations of
p38a-positive lymphocytes in the tumor tissues. The resulting pixel values from each image were subjected to an unpaired t-test with Welch’s
correction by using GraphPad Prism software, to determine the statistical significance of the difference between the SCC sample and normal skin
sample groups. *: p = 0.014. (D) Representative immunohistochemical staining of p38a. (a) Moderately differentiated and (c) well-differentiated
cutaneous SCCs; (b and d) tumor-adjacent skin of (a) and (c), respectively; Representative immunohistochemical staining of phospho-p38. SCC (e) and
its tumor-adjacent skin (f). Arrows indicate positive staining.
doi:10.1371/journal.pone.0097245.g001
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Immunohistochemical (IHC) staining and quantification
Skin SCC tissue arrays (TMAs, Imgenex, IMH-323) were used
in the immunohistochemical assessment of p38a. Sections were
treated with Antigen Unmasking Solution (Vector Labs, Burlin-
game, CA) prior to incubation with primary antibodies and
detection with DAB, as previously described [29] [30]. Images
were obtained using an Axioplan2 microscope. The signal
intensity and the extent of staining were quantified using the
pixel analysis function of Adobe Photoshop. The resulting pixel
values from each image were subjected to an unpaired t-test with
Welch’s correction by using GraphPad Prism software, to
determine statistical significance.
UV light source
A UV Irradiation Unit (Daavlin, Bryan, OH), equipped with an
electronic controller to regulate the dosage, was used. The UV
source consisted of eight FS72T12-UVB-HO lamps that emit
UVB (290–320 nm, 75–80% of total energy) and UVA (320–
380 nm, 20–25% of total energy). A UVC sensor (Goldilux UVC
Probe, Oriel, Stratford, CT) was routinely used during each
exposure to confirm lack of UVC emission. The UV dose was
quantified with a UVB Spectrum 305 Dosimeter obtained from
Daavlin. The radiation was further calibrated with an IL1700
Research Radiometer/Photometer from International Light
(Newburyport, MA).
Tumor study in p53-/-/SKH-1 mice
p53-/-/SKH-1 mice were generated as previously described [31]
by crossing eight-week-old female non-agouti p532/2 mice (B6/
C57BL/6J-Trp532/2, Jackson Laboratories, Bar Harbor, ME)
with SKH-1 males (Charles River Laboratories, Wilmington, MA)
to generate littermates heterozygous for p53. These mice were
then backcrossed for 11 generations to SKH-1 mice to minimize
the C57BL/6 genetic background, and a colony of p532/2/SKH-
1 mice (F14–F16) were utilized for the tumorigenesis studies. Male
or female 8–9 week-old p53-/-/SKH-1 mice were divided into four
groups: Mice in Groups I and II received either 0.5%
methylcellulose by gavage or UV irradiation (180 mJ/cm2),
respectively. Mice in Group III received SB203580 (50 mg/kg
body weight in 0.5% methylcellulose, gavage) and mice in Group
IV received both UV irradiation and SB203580. SB203580 and/
or UV irradiation were applied twice per week for a total of 22
weeks. Tumors were counted weekly once they reached 2 mm in
diameter. At week 22, all mice were sacrificed, their dorsal skin
removed, and tumors were harvested and collected for analysis.
Xenografts of A431 cells
NOD/Shi-scid IL2rgamma(null) (NOG) mice were divided into
four groups of six mice each. Groups I and II received 0.5%
methylcellulose by gavage. Mice in Group III and IV received
SB203580 by gavage (50 mg/kg body weight in 0.5% methylcel-
lulose, three times per week for six weeks). Three days after
starting the drug administration, A431 cells transduced with
control vector (shCTRL) (36104 cells in 100 ml matrigel) were
subcutaneously injected into mice in groups I and III, while mice
in groups II and IV received NOX2 knockdown A431 cells
(shNOX2). Tumor growth was measured every five days for 40
days.
Ethics Statement
The tumor study in p53-/-/SKH-1 mice was carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by Columbia University
Institutional Animal Care and Use. The xenograft study was
performed at the University de Bordeaux; the protocol was
approved by the animal ethics committee there. All efforts were
made to minimize suffering in experimental animals.
Statistics
Statistical analyses were performed using the Student’s t test (two-
tailed) or 1-way ANOVA tests, followed by post-hoc Tukey’s tests.
P,0.05 was considered significant. Results are presented as mean
6 SD. Statistical analyses for TMAs were performed using an
unpaired t-test with Welch’s correction by using GraphPad Prism
software, to determine the statistical significance of the difference
between the SCC sample and the normal skin sample groups.
Results
Differential regulation of p38a MAPK expression in
normal human keratinocytes (NHK) and A431 SCC cells
following UV irradiation
In previous studies, we showed that acute UV irradiation of the
skin of SKH-1 mice activates p38 MAPK signaling, which
Figure 2. p38a inhibition enhances proliferative capacity of
A431 SCC keratinocytes. (A) The effects of p38a inhibition were
assessed by BrdU incorporation in A431 cells transfected with p38a
siRNA (p38aKD), or treated with SB203580 (5 mM (SB/5), 10 mM (SB/10)
for 24 h. Each histogram represents the results from triplicate cultures;
*p,0.05. scr, scrambled control siRNA. The levels of cyclin D1 and
cdc25C in A431 cells treated with the indicated concentrations of
SB203580 for 24 h (B), or following p38a knockdown (C) were assessed
by Western blotting (50 mg protein loaded per lane). b-actin was used
as an internal loading control.
doi:10.1371/journal.pone.0097245.g002
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transiently increases the local pro-inflammatory response [32].
p38a was recently shown to be the dominantly phosphorylated
p38 isoform in response to UV in hTERT-immortalized human
keratinocytes [23], suggesting a role in UV-induced skin carcino-
genesis. We first assessed the effect of UV irradiation on p38
isoforms in NHK and A431 SCC cells. In Fig. 1A, we show that
acute UV irradiation of NHK increased the expression of all four
p38 isoforms (a/b/c/d), but particularly p38b and p38d. In A431
cells, p38a showed a selective reduction in response to UV
(Figs. 1A, 1B), whereas p38b showed a slight increase, as assessed
by Western blotting (Fig. 1B). The level of p38d substantially
increased in UV-irradiated A431 cells compared to non-irradiated
controls, while the levels of p38c were relatively low in both the
non-irradiated and UV-irradiated A431 cells. Additionally, while
the siRNA-mediated knockdown of p38a had no significant effects
on other p38 isoforms in NHK, p38a knockdown in A431 cells led
to the upregulation of p38b and p38d, as determined by real-time
PCR (Fig. S1). These data suggest that the decrease in p38a causes
compensatory increases in p38b and p38d in A431 cells. Taken
together, our results indicate that p38 isoforms are differentially
regulated in response to UV irradiation, in which p38a is
selectively downregulated in A431 cells.
p38a is downregulated in human SCCs
The immunohistochemical assessment of human cutaneous
SCC tissue microarrays demonstrated that the majority of SCCs
either lacked or had reduced p38a expression (Fig. 1C, normal vs.
SCCs, p=0.014). Representative pictures of p38a immunohisto-
chemical staining in paired tumor and tumor-adjacent skin
(Fig. 1D) indicate that p38a is present in both the basal and
suprabasal layers of non-tumor bearing epidermis (b, d), whereas it
was substantially reduced in SCCs (a, c). Furthermore, phosphor-
ylated p38 levels were substantially diminished in SCCs (e, f).
Pharmacological inhibition of p38a MAPK enhances
proliferation of A431 SCC cells lacking functional p53
p38a influences UV stress responses by several pathways,
including its effects on p53. It is known that p53 mutations occur
early during the induction of UV-induced SCCs in humans as well
as in murine models [33,34]. To determine the effects of p38a
deficiency in the absence of p53, we used p38a-expressing A431
cells harboring mutant p53. Both genetic inhibition of p38a via
siRNA-mediated p38a knockdown and chemical inhibition of p38
activity using SB203580 resulted in significant increases in the
proliferation of A431 cells, as measured by BrdU incorporation
(Fig. 2A). This was associated with increased cyclin D1 and
cdc25C (Fig. 2B), which are cell cycle regulators known to be
upregulated in SCC carcinogenesis [30]. These results suggest that
inhibition of the p38 signaling pathway, which likely involves
p38a, drives cell proliferation.
Inhibition of NADPH oxidase decreases proliferation and
invasiveness of p38a-deficient A431 SCC cells
We previously showed that NOX1 is overexpressed in human
SCCs [10]. In A431 cells, p38a knockdown increased NOX2
expression and NADPH oxidase activity that was associated with
Figure 3. Inhibition of NADPH oxidase activity reduces the
cellular proliferation and invasiveness of p38a-deficient A431
SCC keratinocytes. (A) p38a downregulation increases NADPH
oxidase activity and generates intracellular ROS. Intracellular ROS levels
were measured using a cell-permeable fluorogenic probe, 29,79-
dichlorofluorescein diacetate (DCFDA) dye, which detects hydrogen
peroxide production, following siRNA-mediated p38a knockdown in
A431 cells. NOX2 levels were assessed by Western blotting in extracts
prepared from p38a knockdown (p38aKD) A431 cells. NADPH oxidase
activity was determined as previously described [11]. scr, scrambled
control siRNA. Presence of NADPH oxidase inhibitor, DPI (2.5 mM),
inhibits the proliferation (B) and cellular invasiveness (C) of A431 cells
treated with SB203580 or p38aKD A431 cells. Proliferation was
measured by a BrdU incorporation assay, and invasiveness was assessed
in matrigel-coated chambers. Each histogram represents results from
triplicate cultures; *p,0.05.
doi:10.1371/journal.pone.0097245.g003
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increased ROS production (Fig. 3A). Pretreatment of A431 cells
with DPI, a NADPH oxidase inhibitor, abolished the increased
cell proliferation and invasiveness observed in p38a knockdown
and SB203580-treated A431 cells (Fig 3B, C) suggesting a link
between NOX2-dependent ROS generation and cell proliferation
and in vitro invasiveness.
Oral administration of the p38 MAPK inhibitor SB203580
enhances UV-induced skin carcinogenesis in p53-/-/SKH-1
mice.
To elucidate the role of p38 in the pathogenesis of SCCs in the
absence of p53, we utilized our p53-/-/SKH-1 mouse model in a
standard photocarcinogenesis protocol. SB203580 was adminis-
tered orally (50 mg/kg) prior to each UV irradiation (180 mJ/
cm2, twice per week for a total of 22 weeks). As compared to UV-
irradiated mice, SB203580-treated UV-irradiated mice showed a
four-fold increase in the number of skin tumors (Fig. 4A) and a
three-fold increase in average tumor size (Fig. 4B). No tumors
developed in unirradiated SB203580-treated mice. Interestingly,
liver-specific deletion of p38a is known to enhance JNK activity
and the levels of c-Jun, leading to hepatocyte proliferation and
hepatic tumorigenesis [35]. Similarly, we found elevated phos-
phorylated c-Jun and cyclin D1 in SCCs harvested from the UV-
irradiated, SB203580-treated mice (Fig. 4C). Importantly,
SB203580 administration augmented the mRNA and protein
levels of NOX2 (Fig. 4D) and NADPH oxidase activity (Fig. 4E),
suggesting that inhibition of p38 may exacerbate the carcinogenic
effects of UV by driving NOX2-dependent ROS signaling.
NOX2 downregulation suppresses the growth of
SB203580-treated A431 xenograft tumors
To determine whether NOX2 influences tumor growth, A431
cells transduced with shRNA targeting NOX2 (shNOX2) or
control shRNA (shCTRL) were subcutaneously injected into
Figure 4. The p38 MAPK inhibitor SB203580 accelerates UV-
induced skin carcinogenesis and increases NOX2 levels in
p53-/-/SKH-1 mice. The number of skin tumors (A) and tumor size (B)
at week 22 in UV-irradiated p53-/-/SKH-1 mice (UV) were compared to
mice that had received SB203580 alone (SB) or received both SB203580
and UV irradiation (SB/UV). control, non-irradiated, non-treated mice;
*p,0.05, UV vs. SB/UV. (C) The levels of phospho-c-Jun and cyclin D1 in
tissue extracts, assessed by Western blotting. 60 mg total protein per
lane; b-actin was used as an internal loading control. (D) SB203580
administration leads to the upregulation of NOX2 in UV-induced SCCs
in p53-/-/SKH-1 mice. NOX2 levels were detected by RT-PCR (top panel)
and Western blotting (bottom panel). B2M and actin were used as
internal controls for RT-PCR and Western blotting, respectively.
doi:10.1371/journal.pone.0097245.g004
Figure 5. NOX2 silencing suppresses the growth of A431
xenografts treated with SB203580. The in vivo tumor growth of
NOX2 knockdown A431 cells subcutaneously injected into NOG mice,
which were either treated or not treated with SB203580 (SB+shNOX2 or
shNOX2, respectively). A431 cells were transduced three days prior to
injection. shCTRL, A431 cells transduced with control shRNA; SB+
shCTRL, A431 cells transduced with control shRNA and treated with
SB203580. Results are presented as mean 6 SD. * p,0.05, **p,0.001
SB+shCtrl vs. shCtrl; u p= 0.032, SB+shCtrl vs. SB+shNOX2.
doi:10.1371/journal.pone.0097245.g005
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immunodeficient NOG mice (n = 12 each group). These mice
were further divided into two groups of six mice each, of which
one group received SB203580 (50 mg/kg, gavage, three times per
week for six weeks), while the other groups received a methylcel-
lulose vehicle. Consistent with the data observed in UV-irradiated
p53-/-/SKH-1 mice in Fig. 4, the growth of A431 xenografts were
substantially enhanced in mice treated with SB203580 (Fig. 5;
shCTRL vs. SB+shCTRL). NOX2 silencing suppressed this
growth by 50% (SB+shCTRL vs. SB+shNOX2). Interestingly,
NOX2 silencing alone did not significantly affect the growth of
A431 xenografts (shNOX2; Fig. 5). These data indicate a direct
relationship between p38 and NOX2 and suggest NOX2 as a
potential therapeutic target for SCCs with diminished p38 activity.
Discussion
p38a is generally considered to be a tumor suppressor; however,
studies performed in various model systems suggest that p38a may
have dualistic or context-dependent effects in regulating cell death
and survival, in part due to substrate specificity and sensitivity in
response to specific stimuli. Because UV-induced mutational
inactivation of p53 is an important driver of cutaneous SCCs, we
employed p53-deficient A431 SCC cells and a p53-/-/SKH-1
mouse model to assess the p53-independent role of p38a in skin
carcinogenesis. Genetic inhibition of p38a or pharmacological
inhibition of p38 activity with SB203580 increased the prolifer-
ation and invasiveness of A431 cells (Figs. 2, 3), and the oral
administration of SB203580 augmented the growth of UV-
induced SCCs in p53-/-/SKH-1 mice (Fig. 4). Further confirma-
tion of our results comes from our observation that p38a is
decreased in human primary SCCs compared to non-tumor
bearing skin and in UV-irradiated A431 cells (Fig. 1), suggesting its
role in tumor suppression. Our results are consistent with those of
Qiang et al [22], who showed that autophagy-associated decreases
in p38 phosphorylation enhances cell survival [22]. p38 activity
was also found to be reduced in human SCCs, compared to
normal human skin [22]. Moreover, inhibition of p38 signaling
was associated with a defect in global genome nucleotide excision
repair (GG-NER), a vitally important tumor protective pathway
that recognizes and excises UVB-induced CPDs (cyclobutane
pyrimidine dimers) and 6-4PPs (pyrimidine (6-4) pyrimidone
photoproducts) that would otherwise be mutagenic [36]. These
data indicate that p38a loss can promote UV-induced skin
tumorigenesis. Our results, however, differ from those of
Dickinson et al. who reported that a dominant negative mutant
of p38a (p38aDN) SKH-1 mice, consisting of T180A and Y182F
point mutations at the Thr-Gly-Tyr activation site [26,37], were
resistant to UV-induced skin carcinogenesis [37]. Similarly, using
the same p38aDN model, Dong et al demonstrated that p38
blockade resulted in fewer and smaller tumors in response to
ultraviolet radiation [38]. The explanation for these conflicting
results is unclear, but several possibilities can be considered. For
example, our study utilized p53–/–/SKH mice and cultured p53-
mutant human cells. Given the synergistic interaction between p38
and p53 in cell-cycle regulation [25], we postulate that, in the
absence of p53, p38a could compensate for the loss of the p53
tumor-suppression function; this may explain the augmented UV-
induced skin carcinogenesis observed in SB203580-treated
p53–/–/SKH mice. In addition to the p53 functional status, other
factors could contribute to the observed discrepancy: differential
modes of p38 inhibition, the role of other p38 isoforms, differential
inflammatory responses, and the source of UV (i.e., the UV
radiation employed in our study comprised 75–80% UVB and 20–
25% UVA of total energy, whereas Dong and colleagues used
95% UVA and 5% UVB [38]).
While p38a has been shown to be predominantly sensitive to
SB203580 in certain cases—for example, in primary fibroblast
[27]—SB203580 is known to target both p38a and p38b isoforms.
Coupled with our data showing the presence of p38b and its UV-
induced increase in A431 cells (Fig. 1), as well as a compensatory
increase of p38b following p38a knockdown (Fig. S1), it is possible
that the effect of SB203580 can be attributed to the inhibition of
both p38a and p38b, and not solely p38a. Additionally, it is
interesting to note that the p38d level increased in p38a
knockdown A431 cells; no such effects were seen in normal
human keratinocytes (Fig. S1). The p38d level was also increased
in UV-irradiated A431 cells (Fig. 1B). In a study that employed
two-stage 7,12-dimethylbenz(a)anthracene/12-O-tetradecanoyl-
phorbol-13-acetate chemical skin carcinogenesis, mice lacking
p38d were resistant to the development of benign papillomas [39];
this suggests that p38d promotes tumorigenesis. Whether p38d
indeed promotes SCC tumorigenesis and whether it plays a similar
role in UV-induced skin carcinogenesis remains unknown.
Nonetheless, these data collectively suggest a complex interplay
among p38 isoforms during skin responses to UV radiation and
warrant further investigation, if we are to understand the
functional relevance of these compensatory increases in UV
carcinogenesis and the specific contribution of the individual p38
isoforms that underlie skin cancer pathogenesis.
Immunohistochemical assessments of p38a in human cutaneous
SCC tissue arrays indicate that p38a levels are reduced in tumors,
compared to non-tumor-bearing skin (Fig. 1). The mechanism
underlying p38a downregulation is not clear. Recently, it was
shown that UV irradiation of HaCaT cells, a spontaneously
immortalized skin keratinocyte cell line, harboring mutant p53
induces NF-kB-mediated miR-125b expression, which repressed
p38a levels by targeting its 39-UTR [17]. miR-125b-mediated
p38a repression was also shown to protect cells against UV-
induced apoptosis, thereby promoting cell survival [17]. The
combination of the absence of functional p53 and UV-induced
p38a repression likely provide a survival advantage that acceler-
ates tumor promotion and progression. Further research assessing
the status of p38a and p53 in tumors developed in p38aDN mice
and p53-/-/SKH-1 and p53+/+/SKH-1 mice in response to UV
may help clarify the relationship between p38a and p53 in skin
carcinogenesis.
It is important to note, however, that a previous study using
high-density oligonucleotide arrays identified p38a expression as
being moderately increased (1.4-fold) at the mRNA level in human
cutaneous SCCs [40]. Junttila and colleagues also reported that
p38a mRNA is expressed in head and neck SCC (HNSCC) cell
lines at levels comparable to that in normal squamous epithelial
cells [15]. Since our results were based on IHC—to facilitate
comparisons of protein levels between cutaneous SCCs and
normal skin—the lack of p38a protein in our study could indicate
a possible post-transcriptional control of p38a during SCC
tumorigenesis.
Our results indicate that p38a loss during SCC pathogenesis is
accompanied by enhanced NOX2 expression leading to increased
intracellular ROS levels and that NOX2 downregulation sup-
presses the growth of A431 xenografts (Figs. 3, 5). Given that the
p38a protein does not possess DNA-binding activity, its role in
NOX2 regulation is likely to be indirect and perhaps involves
transcription factors known to be direct targets of p38 [41].
Additionally, p38a phosphorylates serine residues in the N-
terminal tail of histone H3 (Ser10 and Ser28) [42] [43], suggesting
a potential for epigenetic reversible regulation of gene expression
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[44] [45]. In A431 cells, p38a knockdown increased the DNA-
binding activity of the transcription factor AP-1, and we have
identified putative AP-1 recognition sites in the NOX2 promoter
(data not shown). Further studies are needed to define the
mechanisms by which p38a regulates NOX2 expression and the
relevance to UV-induced skin tumorigenesis. Identification of UV-
specific p38a substrates, as well as modulation of p38a expression
in genetically modified murine skin cancer models in a time- and
tissue-specific manner, will aid in understanding its effects on
signaling pathways that are relevant to skin carcinogenesis and
may also help to determine whether restoration of p38a expression
can prevent the development of these tumors.
Supporting Information
Figure S1 siRNA-mediated knockdown of p38a has no
significant effects on other p38 isoforms in NHKs (left
panel), but led to compensatory upregulation of p38b
and p38d in SCC cells (right panel).
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